Grants and Contributions:
Title:
2425-HQ-000040
Agreement Number:
2425-HQ-000040
Agreement Value:
$48,787,766.00
Agreement Date:
Feb 27, 2025 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Winnipeg, Manitoba, CA R3B 3M9
Reference Number:
271-2025-2026-Q1-00033
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
Government
Additional Information:
The total agreement value previously disclosed has been updated to reflect an increase resulting from this amendment.
Amendment Date
May 8, 2025
Recipient's Legal Name:
Manitoba Health, Seniors and Active Living
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs
Amendments: